The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference
Free Sign Up
Attend The Microcap Conference
No Result
View All Result
The Microcap Newsletter
No Result
View All Result

IPO Flow Still Slow

Fed’s Rate Hike Halt Offers Breathing Room

June 19, 2023

The IPO flow remains slow with an abbreviated week due to the Juneteenth holiday.

Last Wednesday, the Federal Reserve skipped a rate hike after 10 increases dating back to March 2022.

The rate hike halt provides essential breathing room for investors amidst concerns about inflation.

However, the central bank may hike rates later this year. Half the committee anticipates rates will increase another half-point.

Matt Kennedy, the Senior IPO Market Strategist for Renaissance Capital, stated last week on CNBC’s “ETF Edge,” “We do see a light at the end of the tunnel. All the pieces are finally in place for pickup in the second half.”

Tech investment opportunities are at the forefront with 54 percent of US IPOs referencing AI in their prospectuses in the year-to-date. This week’s offerings include a green pesticide company and a digital marketing provider.

Green Pesticides to Grow Green Products

Med-X (MXRX) has an estimated IPO date of June 21 and seeks to raise $8.5 million at a nearly $21.5 million market cap. Founded in 2014 and based in the United States, Med-X supplies environmentally friendly health and wellness products to pest control and other industries under the trade names Thermal-Aid, Nature-Cide, and Malibu Brands. The Nature-Cide products are essential oil blends used for indoor and outdoor pesticides, developed for industries like hospitality, turf care, vector control, janitorial, school districts, and agriculture including the hemp and cannabis industries.

The company booked $1 million in revenue for the year ended June 30, 2022. The joint bookrunners on the deal are EF Hutton and Craft Capital Management.

The Face of the Alcoholic Beverage Space

LQR House (LQR) announced terms for its IPO on June 15 and intends to raise $5 million at an estimated $56 million market cap. Founded in 2021 and based in the United States, the company provides brand development and digital marketing in the alcoholic beverage space. LQR House has a partnership with Country Wine & Spirits (CWS) holding the rights for all marketing elements, and the exclusive CWS influencer network acts as LQR affiliates. LQR House has also established a wine club and developed limited batch spirit brands.

LQR House booked $1 million in revenue for the year ended March 21, 2023. EF Hutton is the sole bookrunner on the deal.

Recent Posts

Bi-Monthly Report on SEC Oversight of Penny Stock Violations

SEC: Unregistered Dealer Profits from Distressed Penny-Stock Sales

March 11, 2024
Microcap IPO Flow Remains Strong into September

Microcap IPO Flow Holds Steady into Mid-March

March 11, 2024
Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts

March 11, 2024
DealFlow Events logo

PO Box 122
Syosset, NY 11791
(516) 876-8006
team@dealflowevents.com

Twitter

Subscribe to our free newsletter

Stay informed on the latest weekly Microcap news.

SIGN UP

Sponsored content, this is a paid promotion

Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.

© DealFlow Financial Products, Inc. (d/b/a DealFlow Events). All rights reserved. DealFlow Events™ and The Microcap Conference™ and The Microcap Newsletter™ are trademarks of DealFlow Financial Products, Inc.

  • Deal Tables
  • News
  • Events
    • The Microcap Conference
    • The SPAC Conference
    • The Reg A Conference
    • The Venture Debt Conference
    • The DTC Healthcare Conference
    • The Healthcare Services
      Investment Conference
  • Free Sign Up
  • Register for The Microcap Conference